Herbalife Q2 adj. EBITDA $180M, beats guidance; FY 2024 EBITDA raised

HERBALIFE LTD.

2024-Q2 EPS reported $0.29 revenue$2,545,400,000

Net sales $1.3B, down 2.5% YoY but constant currency up 0.2%, driven by Latin America, EMEA, Asia Pacific.
Adjusted EBITDA $180M (highest in 7 quarters), margin up 120 bps YoY; exceeds guidance.
Diluted EPS $0.05; adjusted EPS $0.54; restructuring ($0.33) and debt extinguishment ($0.07) headwinds.
Total leverage ratio reduced to 3.5x; completed sale-leaseback of Torrance, CA office in July.
Full-year 2024 guidance: net sales forecast lowered, adjusted EBITDA raised; capex reaffirmed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.